查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433415

全球支气管活检设备市场 2023-2030

Global Bronchial Biopsy Devices Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

预计全球支气管活检设备市场在预测期内将以 7.4% 的CAGR成长。关键因素包括肺癌、慢性阻塞性肺病（COPD）等呼吸系统疾病的流行、老年人口的增加以及推动市场成长的微创手术需求的增加。据肺癌研究基金会称，到 2023 年，美国估计将有 238,340 人被诊断出患有肺癌。每 16 个人中就有 1 人患有肺癌，其中每 16 名男性中就有 1 名患有肺癌，每 17 名女性中就有 1 名患有肺癌。此外，人口老化更容易患呼吸道疾病，这增加了对支气管活检等诊断程序的需求，以解决这些健康问题。 2022年11月，《老年人口统计：美国老化肖像》一文报道称，美国有5,410万成年人，即16.3%的老年人是老年人，其中包括65岁或以上的老年人。预计到 2040 年，老年人口将增至 22.0%，到 2060 年将增至 25.0%。

细分市场前景

全球支气管活检设备市场按产品和最终用户进行细分。根据产品，市场细分为活检钳、经支气管针吸 (Tbna) 针和细胞刷。此外，根据最终用户，市场细分为医院、诊断成像中心、研究和学术机构等。其他包括乳房护理中心。在最终用户中，由于设施先进、交通便利、交通和住房援助，医院细分市场预计将占据相当大的市场份额。

经支气管针抽吸 (Tbna) 针子细分市场预计将在全球支气管活检设备市场中占据相当大的份额

其中，由于全球肺癌盛行率不断上升，加上对准确、经济高效和微创诊断的需求，TBNA针子细分市场预计将在全球支气管活检设备市场中占据相当大的份额。程序，促进了滨海新区设备的需求。据美国国立卫生研究院 (NIH) 称，在过去的十年中，支气管内超音波引导下的 TBNA (EBUS-TBNA) 已成为评估未确诊胸内淋巴结肿大的首选诊断程序。 EBUS-TBNA是目前肺癌纵膈分期的首选方法。根据发表的题为「支气管内超音波引导经支气管针抽吸：技术与挑战」的文章，在印度各地的669 名呼吸科医生中，只有27.0% 的印度受访呼吸科医生进行了EBUS-TBNA，而74% 的人使用了传统的TBNA。这些因素迫使主要参与者推出产品来满足市场上产品的需求。 2023 年 9 月，Broncus Medical 推出了用于微创诊断应用的新型 BioStar 经支气管抽吸针 (TBNA)。它设计用于传统 TBNA (cTBNA) 和 EBUS-TBNA 诊断技术。该公司提供 21G、22G 和 25G 配置的针。

区域展望

全球支气管活检设备市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于肺癌盛行率不断上升，政府措施和医疗保健政策具有凝聚力，新兴经济体医疗保健基础设施的改善正在推动支气管活检设备市场，预计亚太地区将在全球市场中占据显着份额在亚太地区。

北美地区预计全球支气管活检设备市场将以显着的CAGR成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。由于医疗保健产业发达，加上呼吸道疾病盛行率不断上升，北美市场正在不断成长。此外，意识的提高、对创新支气管活检设备的需求不断增加以及医疗保健支出的增加预计将在预测期内推动市场成长。根据经济合作暨发展组织（OECD）的数据，2021年，美国医疗保健支出占国内生产毛额（GDP）的17.8%，几乎是经合组织国家平均水准的两倍。此外，根据医疗保险和医疗补助服务中心 (CMMS) 2022 年 3 月发布的资料，报告发现，2021-2030 年国家医疗支出年均增长预计为 5.1%，达到近 6.8 兆美元至2030 年。同期国家GDP 预计每年增长5.1%。根据可比较的预测成长率，预计 2030 年卫生保健占 GDP 的比重将为 19.6%，与 2020 年 19.7% 的比重几乎相同。因此，该国不断增长的医疗支出预计将增加公司活动和政府在开发高效能支气管活检设备方面的倡议，从而推动市场成长。

市场参与者展望

服务于支气管活检设备市场的主要公司包括 Becton、Dickinson, and Co.、Cook Medical Inc.、CONMED Corp.、Medtronic plc 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2023 年 5 月，Menarini Silicon Biosystems 与 Alivio Health 合作，扩大患者获得 CELLSEARCH (R) 液体活检测试的机会。该协议允许 Alivio Health 的客户和提供者优先获得 CELLSEARCH CTC 测试，从而促进不同疾病阶段的癌症患者的纵向监测。

报告涵盖：

  • 2023年市场价值资料分析及2031年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 在全球支气管活检设备市场运营的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Becton, Dickinson, and Co.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Cook Medical Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • CONMED Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Medtronic plc
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 全球支气管活检设备市场（按产品）
    • 切片钳
    • 经支气管针吸抽吸 (Tbna) 针
    • 细胞学刷
    • 液体切片仪器
  • 全球支气管活检设备市场（按最终用途）
    • 医院
    • 诊断影像中心
    • 研究和学术机构
    • 其他（乳房护理中心）

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Argon Medical Devices Inc.
  • B. Braun Medical Inc.
  • Boston Scientific Corp.
  • Cardinal Health, Inc.
  • F. Hoffmann-La Roche AG
  • Fujifilm Corp.
  • Hobbs Medical Inc.
  • Hologic, Inc.
  • Horizons International Corp.
  • INRAD Inc.
  • NeoGenomics Laboratories, Inc
  • Olympus Corp.
  • QIAGEN, Inc.
  • Stryker Corp.
  • Telemed Systems, Inc.
Product Code: OMR2028066

Global Bronchial Biopsy Devices Market Size, Share & Trends Analysis Report by Product (Biopsy Forceps, Transbronchial Needle Aspiration (Tbna) Needles, and Cytology Brushes), and by End-Use (Hospitals, Diagnostic Imaging Centers, Research and Academic Institutes, and Others), Forecast Period (2024-2031)

The global bronchial biopsy devices market is anticipated to grow at a CAGR of 7.4% during the forecast period. Pivotal factors include prevalence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), rising geriatric population, and increasing demand for minimally invasive procedures driving the market growth. According to the Lung Cancer Research Foundation, in 2023, an estimated 238,340 people will be diagnosed with lung cancer in the US. Lung cancer affected 1 in 16 persons in their lifetime 1 in 16 males and 1 in 17 women. Further, the ageing population is more inclined to respiratory diseases, which increases the demand for diagnostic procedures such as bronchial biopsies to address these health issues. In November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans", reported 54.1 million adults or 16.3% of the US population are seniors including aged 65 or older. The senior population is expected to rise to 22.0% by 2040 and 25.0% by 2060.

Segmental Outlook

The global Bronchial Biopsy Devices market is segmented on the product, and end user. Based on the product, the market is sub-segmented into biopsy forceps, transbronchial needle aspiration (Tbna) needles, and cytology brushes. Further, based on end user, the market is sub-segmented into hospitals, diagnostic imaging centers, research and academic institutes, and others. Other includes breast care centers. Among the end users, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the advance facilities, easily accessible, transportation and housing assistance.

The Transbronchial Needle Aspiration (Tbna) Needles Sub-Segment is Anticipated to Hold a Considerable Share of the Global Bronchial Biopsy Devices Market

Among the product, the TBNA needles sub-segment is expected to hold a considerable share of the global bronchial biopsy devices market, owing to the rising prevalence of lung cancer globally, coupled with the demand for accurate, cost-effective, and minimally invasive diagnostic procedures, contributing to the demand for TBNA devices. According to the National Institutes of Health (NIH), over the past decade, endobronchial ultrasound-guided TBNA (EBUS-TBNA) has become the preferred diagnostic procedure for evaluating undiagnosed intrathoracic lymphadenopathy. EBUS-TBNA is currently the preferred method for mediastinal staging of lung cancer. As per the published article titled "Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: Techniques and Challenges," among 669 respiratory physicians throughout India, only 27.0% of surveyed respiratory physicians in India performed EBUS-TBNA, while 74% used conventional TBNA. Such factors compelled the key players to launch product to carer the demand of the product in the market. In September 2023, Broncus Medical introduced the new BioStar Transbronchial Aspiration Needle (TBNA) for minimally invasive diagnostic applications. It has been designed to be used for both conventional TBNA (cTBNA) and EBUS-TBNA diagnostic techniques. The company offers the needle in 21G, 22G and 25G configurations.

Regional Outlook

The global bronchial biopsy devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising prevalence of lung cancer, cohesive government initiatives and healthcare policies, improving healthcare infrastructure in emerging economies are driving the bronchial biopsy devices market in the Asia-Pacific.

The North America Region is Expected to Grow at a Significant CAGR in the Global Bronchial Biopsy Devices Market

Among all regions, North America region is anticipated to grow at a considerable CAGR over the forecast period. The North America market is growing owing to the presence of a well-developed healthcare sector, along with the rising prevalence of prevalence of respiratory diseases. Additionally, rising awareness, increasing demand for innovative bronchial biopsy devices, and rising healthcare expenditure are projected to drive market growth during the forecast period. According to the Organization for Economic Co-operation and Development (OECD), in 2021, the US spent 17.8% of gross domestic product (GDP) on healthcare, nearly twice as much as the average OECD country. Additionally, as per the data published by the Centers for Medicare & Medicaid Services (CMMS), in March 2022, the report found that annual growth in national health spending is projected to average 5.1% over 2021-2030, and to reach nearly $6.8 trillion by 2030. Growth in the nation's GDP is also anticipated to be 5.1% annually over the same period. As a result of the comparable projected rates of growth, the health share of GDP is expected to be 19.6% in 2030, nearly the same as the 2020 share of 19.7%. Thus, the growing health spending in the country is estimated to increase company activities and government initiatives in developing efficient bronchial biopsy devices, thus pushing the market growth.

Market Players Outlook

The major companies serving the bronchial biopsy devices market include Becton, Dickinson, and Co., Cook Medical Inc., CONMED Corp., Medtronic plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2023, Menarini Silicon Biosystems partnered with Alivio Health to expand patient access to CELLSEARCH® liquid biopsy tests. The agreement allowed Alivio Health clients and providers preferred access to CELLSEARCH CTC tests, facilitating longitudinal monitoring of cancer patients at different disease stages.

The Report Covers:

  • Market value data analysis of 2023 and forecast to 2031.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global bronchial biopsy devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Becton, Dickinson, and Co.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Cook Medical Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. CONMED Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Medtronic plc
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Bronchial Biopsy Devices Market by Product
    • 4.1.1. Biopsy Forceps
    • 4.1.2. Transbronchial Needle Aspiration (Tbna) Needles
    • 4.1.3. Cytology Brushes
    • 4.1.4. Liquid Biopsy Instruments
  • 4.2. Global Bronchial Biopsy Devices Market by End-Use
    • 4.2.1. Hospitals
    • 4.2.2. Diagnostic Imaging Centers
    • 4.2.3. Research and Academic Institutes
    • 4.2.4. Others (Breast Care Centers)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Argon Medical Devices Inc.
  • 6.2. B. Braun Medical Inc.
  • 6.3. Boston Scientific Corp.
  • 6.4. Cardinal Health, Inc.
  • 6.5. F. Hoffmann-La Roche AG
  • 6.6. Fujifilm Corp.
  • 6.7. Hobbs Medical Inc.
  • 6.8. Hologic, Inc.
  • 6.9. Horizons International Corp.
  • 6.10. INRAD Inc.
  • 6.11. NeoGenomics Laboratories, Inc
  • 6.12. Olympus Corp.
  • 6.13. QIAGEN, Inc.
  • 6.14. Stryker Corp.
  • 6.15. Telemed Systems, Inc.

LIST OF TABLES

  • 1. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 2. GLOBAL BIOPSY FORCEPS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 3. GLOBAL TRANSBRONCHIAL NEEDLE ASPIRATION (TBNA) BRONCHIAL BIOPSY NEEDLES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 4. GLOBAL CYTOLOGY BRONCHIAL BIOPSY BRUSHES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 5. GLOBAL LIQUID BIOPSY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 6. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
  • 7. GLOBAL BRONCHIAL BIOPSY DEVICES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 8. GLOBAL BRONCHIAL BIOPSY DEVICES FOR DIAGNOSTIC IMAGING CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 9. GLOBAL BRONCHIAL BIOPSY DEVICES FOR RESEARCH AND ACADEMIC INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 10. GLOBAL BRONCHIAL BIOPSY DEVICES FOR OTHER END-USE MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 11. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 12. NORTH AMERICAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 13. NORTH AMERICAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 14. NORTH AMERICAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
  • 15. EUROPEAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 16. EUROPEAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 17. EUROPEAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
  • 18. ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 19. ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 20. ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
  • 21. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 22. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 23. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023 VS 2031 (%)
  • 2. GLOBAL BIOPSY FORCEPS MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 3. GLOBAL TRANSBRONCHIAL NEEDLE ASPIRATION (TBNA) BRONCHIAL BIOPSY NEEDLES MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 4. GLOBAL CYTOLOGY BRONCHIAL BIOPSY BRUSHES MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 5. GLOBAL LIQUID BIOPSY INSTRUMENTS MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 6. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023 VS 2031 (%)
  • 7. GLOBAL BRONCHIAL BIOPSY DEVICES FOR HOSPITALS MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 8. GLOBAL BRONCHIAL BIOPSY DEVICES FOR DIAGNOSTIC IMAGING CENTERS MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 9. GLOBAL BRONCHIAL BIOPSY DEVICES FOR RESEARCH AND ACADEMIC INSTITUTES MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 10. GLOBAL BRONCHIAL BIOPSY DEVICES FOR OTHER END-USE MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 11. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 12. US BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 13. CANADA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 14. UK BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 15. FRANCE BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 16. GERMANY BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 17. ITALY BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 18. SPAIN BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 19. REST OF EUROPE BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 20. INDIA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 21. CHINA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 22. JAPAN BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 23. SOUTH KOREA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 25. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)